Opportunities and Challenges for Regional Coordination of Infectious Disease Control Comment on "Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks".

Disease Control Infectious Disease Networks Scoping Review

Journal

International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905

Informations de publication

Date de publication:
19 12 2022
Historique:
received: 13 07 2022
accepted: 20 11 2022
medline: 17 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: ppublish

Résumé

This commentary cites a scoping review by Durrance-Bagale et al (2021) on how regional bodies have approached infectious disease control to determine if those lessons could be applied to assist the Association of Southeast Asian Nations (ASEAN). The author's work is timely and highlights the importance of recognizing and understanding regional context, governance and operational structures to then design effective regional networks. Most factors highlighted as enablers and constraints are quite expected, including stakeholder mapping, a clear mission space with goals and objectives, outreach and advocacy to receive buy-in, political will and sustainable funding. We suggest below that there is an opportunity for further systematic and operational research of enablers and constraints for regional infectious disease control bodies, one that expands on infectious disease control while also continuing to take into account governance, legislative and organizational factors, and strongly emphasizes the development and application of clear metrics to create better measures of impact.

Identifiants

pubmed: 37579350
doi: 10.34172/ijhpm.2022.7533
pmc: PMC10105202
doi:

Types de publication

Review Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

3145-3147

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2022 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Références

BMC Public Health. 2019 May 10;19(Suppl 3):473
pubmed: 32326911
Int J Health Policy Manag. 2022 Dec 6;11(11):2392-2403
pubmed: 35042324
Emerg Health Threats J. 2013;6:
pubmed: 23362413
Biosecur Bioterror. 2009 Dec;7(4):399-404
pubmed: 20028248
Int J Health Policy Manag. 2022 Dec 19;11(12):3141-3144
pubmed: 35942957

Auteurs

Claire J Standley (CJ)

Department of Microbiology & Immunology, Center for Global Health Science and Security, Georgetown University Medical Center, Washington, DC, USA.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Erin M Sorrell (EM)

Department of Microbiology & Immunology, Center for Global Health Science and Security, Georgetown University Medical Center, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH